Latest available resultsQuarter ended June 30, 202610-Q · July 23, 2026
Filed with the SECQUEST DIAGNOSTICS INC
DGXHealthcare
Next reportOctober 19, 2026pre-market · Analyst forecast 2.881 $/share
Revenue
$3.04B
▲ +10.2% vs prior year% YoY
Net income
$320.00M
▲ +13.5% vs prior year% YoY
EPS
2.84$
▲ +15.0% vs prior year% YoY
Net margin
10.5%
▲ +0.3 percentage points vs prior year pp YoY
Revenue▲ +10.2 %
Margins (% of revenue)GrossOperatingNet
Net income▲ +13.5 %
EPS▲ +15.0 %
View financial tableQuarter ended June 30, 2026
| Metric | Value | Context |
|---|---|---|
| Operations | ||
| Revenue | $3.04B | |
| Gross profit | $1.03B | 33.7 % |
| Operating income | $459.00M | 15.1 % |
| Net income | $320.00M | 10.5 % |
| R&D | — | never filed |
| EPS (diluted) | 2.84 $ | |
| Balance sheet | ||
| Assets | $16.94B | |
| Liabilities | $9.12B | |
| Equity | $7.82B | |
| Cash | $626.00M | |
| Capital | ||
| Shares outstanding | 110.37M | as of 2026-07-15 |
| Public float | — | |